Insights on the Pharma Regulatory Management Systems United States Market to 2027 - Featuring Acolad, Acuta and Antares Vision Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharma Regulatory Management Systems Market Research Report by Component (Services and Solution), Deployment, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Pharma Regulatory Management Systems Market size was estimated at USD 168.24 million in 2021, USD 186.98 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.18% to reach USD 353.73 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharma Regulatory Management Systems Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report answers questions such as:

1. What is the market size and forecast of the United States Pharma Regulatory Management Systems Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the United States Pharma Regulatory Management Systems Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Pharma Regulatory Management Systems Market?

4. What is the competitive strategic window for opportunities in the United States Pharma Regulatory Management Systems Market?

5. What are the technology trends and regulatory frameworks in the United States Pharma Regulatory Management Systems Market?

6. What is the market share of the leading vendors in the United States Pharma Regulatory Management Systems Market?

7. What modes and strategic moves are considered suitable for entering the United States Pharma Regulatory Management Systems Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Pharma Regulatory Management Systems Market, by Component

6.1. Introduction

6.2. Services

6.2.1. Managed Services

6.2.2. Professional Services

6.3. Solution

6.3.1. IDMP/Compliance Management

6.3.2. Regulatory Information Management

6.3.3. Regulatory Submissions Management System

7. Pharma Regulatory Management Systems Market, by Deployment

7.1. Introduction

7.2. On-Cloud

7.3. On-Premises

8. Pharma Regulatory Management Systems Market, by End User

8.1. Introduction

8.2. Government Agencies

8.3. Hospitals & Care Providers

8.4. Pharmaceutical & Biotechnology Companies

9. California Pharma Regulatory Management Systems Market

10. Florida Pharma Regulatory Management Systems Market

11. Illinois Pharma Regulatory Management Systems Market

12. New York Pharma Regulatory Management Systems Market

13. Ohio Pharma Regulatory Management Systems Market

14. Pennsylvania Pharma Regulatory Management Systems Market

15. Texas Pharma Regulatory Management Systems Market

16. Competitive Landscape

16.1. FPNV Positioning Matrix

16.1.1. Quadrants

16.1.2. Business Strategy

16.1.3. Product Satisfaction

16.2. Market Ranking Analysis

16.3. Market Share Analysis, By Key Player

16.4. Competitive Scenario

16.4.1. Merger & Acquisition

16.4.2. Agreement, Collaboration, & Partnership

16.4.3. New Product Launch & Enhancement

16.4.4. Investment & Funding

16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles

17.1. Acolad Group

17.2. Acuta, LLC

17.3. Antares Vision

17.4. ArisGlobal LLC

17.5. arivis AG By BioMedion AG

17.6. Computer Sciences Corp

17.7. Dassault Systemes SE

17.8. DDi, Inc

17.9. Dovel Technologies, Inc.

17.10. Ennov SA

17.11. EXTEDO

17.12. Freyr

17.13. Glemser Technologies Corporation

17.14. GlobeMed Ltd

17.15. Health Business Systems Inc.

17.16. Honeywell International Inc

17.17. Idhasoft Ltd

17.18. Informa PLC

17.19. Instem

17.20. MasterControl, Inc.

17.21. MedHOK Inc.

17.22. NNIT

17.23. Parexel International

17.24. pharmaREADY

17.25. Qualityze Inc

17.26. Veeva Systems

17.27. Virtify, Inc.

18. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/rc1v6

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900